Barbara Leuchs

Tumour Virology Division F010, German Cancer Research Center (DKFZ)

Affiliated withGerman Cancer Research Center (DKFZ)

Research Area

Immunology and Infection

Biography

Barbara Leuchs has not added Biography.
If you are Barbara Leuchs and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 8	2012

Other Publications

Article	Year
Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. Cardiovascular research\| PubMed ID: 16448634	2006
Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1. Journal of virology\| PubMed ID: 16501072	2006
Oncolytic murine autonomous parvovirus, a candidate vector for glioma gene therapy, is innocuous to normal and immunocompetent mouse glial cells. Cell and tissue research\| PubMed ID: 16699801	2006
Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucl... Journal of virology\| PubMed ID: 16956943	2006
Arming parvoviruses with CpG motifs to improve their oncosuppressive capacity. International journal of cancer. Journal international du cancer\| PubMed ID: 18360875	2008
Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia protein. World journal of gastroenterology : WJG\| PubMed ID: 18609705	2008
Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19147756	2009
Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors. Antiviral therapy\| PubMed ID: 20032542	2009
Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cells. International journal of cancer. Journal international du cancer\| PubMed ID: 20087864	2010
Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Human gene therapy\| PubMed ID: 20486768	2010
Screening of human tumor antigens for CD4 T cell epitopes by combination of HLA-transgenic mice, recombinant adenovirus and antigen peptide libraries. PloS one\| PubMed ID: 21152437	2010
Comparison of IL-10 and MCP-1-7ND gene transfer with AAV9 vectors for protection from murine autoimmune myocarditis. Cardiovascular research\| PubMed ID: 21354997	2011
Regression of glioma in rat models by intranasal application of parvovirus h-1. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 21715567	2011
Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model. Science translational medicine\| PubMed ID: 21775667	2011
Interferon Î³ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer. Cancer biology & therapy\| PubMed ID: 22024742	2011
Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1. BMC cancer\| PubMed ID: 22029859	2011
Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid. Journal of virology\| PubMed ID: 22258256	2012
Intranasal Vaccination with AAV5 and 9 Vectors Against Human Papillomavirus Type 16 in Rhesus Macaques. Human gene therapy\| PubMed ID: 22401308	2012